HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells.

Abstract
Increased IL-9 expression, either systemically or under the control of lung-specific promoter, induces an asthma-like phenotype, including mucus overproduction, mastocytosis, lung eosinophilia, and airway hyperresponsiveness. These activities correlate with increased production of other Th2 cytokines such as IL-4, IL-5, and IL-13 in IL-9 Tg mice. To determine the exact role of IL-13 in this phenotype, mice overexpressing IL-9 were crossed with IL-13-deficient mice. In these animals, IL-9 could still induce mastocytosis and B lymphocyte infiltration of the lungs. Although IL-9-induced eosinophilia in the peritoneal cavity was not diminished in the absence of IL-13, IL-13 was required for IL-9 to increase eotaxin expression and lung eosinophilia. Mucus production and up-regulation of lung epithelial genes upon IL-9 overexpression were completely abolished in the absence of IL-13. Using hemopoietic cell transfer experiments with recipients that overexpressed IL-9 but were deficient in the IL-9 receptor (IL-9R), we could demonstrate that the effect of IL-9 on lung epithelial cells is indirect and could be fully restored by transfer of hemopoietic cells expressing IL-9R. Mucus production by lung epithelial cells was only up-regulated when hemopoietic cells simultaneously expressed functional IL-9R and IL-13 genes, indicating that IL-13 is not a cofactor but a direct mediator of the effect of IL-9 on lung epithelial cells. Taken together, these data indicate that IL-9 can promote asthma through IL-13-independent pathways via expansion of mast cells, eosinophils, and B cells, and through induction of IL-13 production by hemopoietic cells for mucus production and recruitment of eosinophils by lung epithelial cells.
AuthorsValérie Steenwinckel, Jamila Louahed, Ciriana Orabona, François Huaux, Guy Warnier, Andrew McKenzie, Dominique Lison, Roy Levitt, Jean-Christophe Renauld
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 178 Issue 5 Pg. 3244-51 (Mar 01 2007) ISSN: 0022-1767 [Print] United States
PMID17312173 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccl11 protein, mouse
  • Chemokine CCL11
  • Chemokines, CC
  • Il9r protein, mouse
  • Interleukin-13
  • Interleukin-9
  • Receptors, Interleukin-9
Topics
  • Animals
  • Asthma (genetics, immunology, metabolism, pathology)
  • Chemokine CCL11
  • Chemokines, CC (biosynthesis, immunology)
  • Epithelial Cells (immunology, metabolism, pathology)
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells (immunology, metabolism, pathology)
  • Interleukin-13 (deficiency, immunology)
  • Interleukin-9 (deficiency, immunology)
  • Leukocytes (immunology, metabolism, pathology)
  • Lung (immunology, metabolism, pathology)
  • Mice
  • Mice, Knockout
  • Mucus (immunology, metabolism)
  • Pulmonary Eosinophilia (genetics, immunology, metabolism, pathology)
  • Receptors, Interleukin-9 (deficiency, immunology)
  • Up-Regulation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: